Edesa Biotech
Price & Volume
Stats
See moreOpen | $3.48 |
Previous Close | $3.51 |
Day Range | $3.17-$3.48 |
52W Range | $0.72-$20.32 |
Market Cap | $47.4M |
Shares Short | 203,556 |
Financials
See moreRevenue (12 Mos) | $500 |
Revenue Growth (YoY) | -99.9% |
Gross Profit (12 Mos) | $311,200 |
Diluted EPS | -$1.65 |
News
See moreYahoo Finance • 4 months ago
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
Yahoo Finance • 4 months ago
Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board
Yahoo Finance • 5 months ago
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch
Yahoo Finance • 6 months ago
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment
About
CEO | Dr. Pardeep Nijhawan FRCPC, M.D. |
Address | 100 Spy Court, Markham, ON, Canada, L3R 5H6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |